BRPI0722078A2 - Uso de composição de solução hipertônica em fabricação de medicamentos para promover a cicatrização de ferimento - Google Patents

Uso de composição de solução hipertônica em fabricação de medicamentos para promover a cicatrização de ferimento

Info

Publication number
BRPI0722078A2
BRPI0722078A2 BRPI0722078-2A2A BRPI0722078A BRPI0722078A2 BR PI0722078 A2 BRPI0722078 A2 BR PI0722078A2 BR PI0722078 A BRPI0722078 A BR PI0722078A BR PI0722078 A2 BRPI0722078 A2 BR PI0722078A2
Authority
BR
Brazil
Prior art keywords
solution composition
hypertonic solution
drug manufacturing
injury healing
promote injury
Prior art date
Application number
BRPI0722078-2A2A
Other languages
English (en)
Inventor
Chaoying Zhao
Original Assignee
Chaoying Zhao
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chaoying Zhao filed Critical Chaoying Zhao
Publication of BRPI0722078A2 publication Critical patent/BRPI0722078A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/732—Pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
BRPI0722078-2A2A 2006-12-28 2007-12-19 Uso de composição de solução hipertônica em fabricação de medicamentos para promover a cicatrização de ferimento BRPI0722078A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2006101481451A CN101209344B (zh) 2006-12-28 2006-12-28 高渗液组合物在制备促进伤口愈合的药物中的应用
PCT/CN2007/071264 WO2008080336A1 (en) 2006-12-28 2007-12-19 Use of high osmotic liquid composition in manufacturing medicament for enhancing wound healing

Publications (1)

Publication Number Publication Date
BRPI0722078A2 true BRPI0722078A2 (pt) 2014-04-01

Family

ID=39588149

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0722078-2A2A BRPI0722078A2 (pt) 2006-12-28 2007-12-19 Uso de composição de solução hipertônica em fabricação de medicamentos para promover a cicatrização de ferimento

Country Status (7)

Country Link
US (1) US20100136140A1 (pt)
EP (1) EP2127659A1 (pt)
JP (1) JP2010514707A (pt)
KR (1) KR20090104811A (pt)
CN (1) CN101209344B (pt)
BR (1) BRPI0722078A2 (pt)
WO (1) WO2008080336A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101003331B1 (ko) * 2010-05-11 2010-12-23 조강선 피부 충전제 조성물
IL206739A (en) 2010-06-30 2016-06-30 David Segal An injectable drug containing silitol as an active substance
RU2600166C2 (ru) * 2011-12-04 2016-10-20 Дэвид Л. ЛЬЮ Лекарственное средство, содержащее ионы натрия и ионы кальция, для лечения рака, опухоли и незлокачественной гиперплазии
CN103006555B (zh) * 2013-01-05 2014-08-06 四川美大康佳乐药业有限公司 一种羟乙基淀粉注射液及其制备方法
CN104644669A (zh) * 2013-11-19 2015-05-27 北大方正集团有限公司 一种急救用的代血浆药物组合物及其制备方法
AU2014353853A1 (en) * 2013-11-25 2016-07-07 Biomedical Concepts Llc Composition, system and method for treating skin
KR102740598B1 (ko) * 2015-09-07 2024-12-09 모찌다 세이야쿠 가부시끼가이샤 알긴산 동결 건조 제제
DE102016008533A1 (de) * 2016-07-18 2018-01-18 PlantTec Medical GmbH Arzneimittel
WO2018164128A1 (ja) 2017-03-07 2018-09-13 持田製薬株式会社 アルギン酸液剤
MX2020005879A (es) * 2017-12-07 2020-10-07 Reven Ip Holdco Llc Composiciones administrables vía intravenosa que comprenden ácidos de grado farmacéutico y reguladores del ph, y el uso de las mismas para tratar enfermedades de disfunción mitocondrial, enfermedades metabólicas y de disfunción del modelado de huesos y tejidos.
DE102018000009A1 (de) * 2018-01-04 2019-03-07 PlantTec Medical GmbH Arzneimittel
WO2021029443A1 (en) * 2019-08-14 2021-02-18 RIM, Chol Hak Local hemostatic composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2834320A1 (de) * 1978-08-04 1980-02-28 Tomic Dobrivoje Heilmittel mit entzuendungshemmender und blutstillender wirkung
CN1068778C (zh) * 1998-05-15 2001-07-25 赵超英 救治用的药物组合物及其制备方法

Also Published As

Publication number Publication date
CN101209344A (zh) 2008-07-02
CN101209344B (zh) 2012-07-04
EP2127659A1 (en) 2009-12-02
US20100136140A1 (en) 2010-06-03
JP2010514707A (ja) 2010-05-06
WO2008080336A1 (en) 2008-07-10
KR20090104811A (ko) 2009-10-06

Similar Documents

Publication Publication Date Title
CL2007003609A1 (es) Compuestos derivados de dihidropiridinas sustituidas; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; proceso para producir la composicion farmaceutica; y uso en el tratamiento de una enfermedad mejorada con la inhibicion
CR10769A (es) Improvements in and relating to drive mechanisms suitable for use in drug delicery devices
SV2010003674A (es) Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasa
DK2120878T3 (da) Doseringsform indeholdende to aktive farmaceutiske ingredienser i forskellige fysiske former
BRPI0817200A2 (pt) composições oftálmicas sólida e uso de compostos para fabricação de medicamento
PT2355851T (pt) Novos lípidos e composições para a administração de agentes terapêuticos
BRPI0813105A2 (pt) Derivado de sulfonamida de ácido malônico e uso faramacêutico do mesmo
PT3127551T (pt) Composição imunogénica de pcv2 para atenuar os sintomas clínicos em porcos
BRPI0807487A2 (pt) Uso de antagonistas de il-23 para o tratamento de infecção
BRPI0815613A2 (pt) Composições lipossômicas para administração in vivo de compostos de ácido borônico.
BRPI0814079A2 (pt) Partículas amorfas sólidas e processo para obte-las para uso em medicamento inalável
IL232447A0 (en) Local topical administration formulations containing indoxacarb
SI3202898T1 (sl) Terapevtski sestavki nukleaze in postopki
SMT201500206B (it) Composti spiro-ossindolici e loro uso come agenti terapeutici
BR112012002331A2 (pt) composição antiviral, composição farmacêutica e uso de quantidade efetiva de composição farmacêutica
BRPI1008045A2 (pt) derivados de aminotetralina, composições farmacêuticas contendo-os, e seu uso em terapia
SV2009003098A (es) Arilimidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina
BRPI1011876A2 (pt) "composição farmacêutica estável e métodos de uso da mesma"
CL2007003645A1 (es) Compuestos parasiticidas derivados de aril-pirazoles sustituidos; compuestos intermediarios; composicion farmaceutica; y uso para tratar una infeccion parasitaria.
IL216668A (en) Pharmaceutical composition and use thereof for preparation of a medicament for emergency contraception
BRPI0821115A2 (pt) Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto
BRPI0920355A2 (pt) composições farmacêuticas tópicas estáveis de ozenoxacina e uso de ozenoxacina
BRPI0813947A2 (pt) Uso de estriol em baixas doses
BRPI0722183A2 (pt) Composições farmacêuticas para tratar depressão e ansiedade
BRPI1011412A2 (pt) composição para liberação sustentada de droga compreendendo alutinante geopolimérico

Legal Events

Date Code Title Description
B08L Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 3A, 4A, 5A E 6A ANUIDADES.

B08I Application fees: publication cancelled [chapter 8.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2277 DE 26/08/2014 POR TER SIDO INDEVIDA.

B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 3A, 4A, 5A, 6A, 7A, 8A, 9A, 10A, 11A E 12A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.